Upload
bertha
View
94
Download
1
Tags:
Embed Size (px)
DESCRIPTION
Herbal drugs/ Pharmaceuticals – Problems and Prognosis. Dr. P. Pushpangadan Director, National Botanical Research Institute Lucknow, India. 5 trillion $. 2020. Herbal drugs. 2005. 62 billion $. Growing popularity. Business standard, 2005. Drugs Required for masses. ccessible - PowerPoint PPT Presentation
Citation preview
Herbal drugs/ Pharmaceuticals – Problems and Prognosis
Dr. P. Pushpangadan
Director, National Botanical Research Institute
Lucknow, India
Growing popularity
5 trillion $ 20202020
2005200562 billion $
Business standard, 2005
ccessible
ffordable
ssured safety
About 70% Indian population (60-70 crore) depends on alternative system of medicine.
WHO
Herbal drugs are cheaper than generic drugs !!??
Herbal drugs have been used in India for more than 4000 years.
Allopathy or Modern Medicine
Glamorized discipline Pursued by most (influenced and so called
‘Literate’) in India and, in western countries Backed by technological advances -
investigations Based on sound scientific reasoning –
experimental evidence; not anecdotal Thus, Modern Medicine is an evidence-
based, techno-savvy science that seems to provide ultimate care to sick patients
Allopathy or Modern Medicine But????
The treatment is often symptomatic, costly, out of reach of most in developing countries
Except for infective pathologies, we do not have much to offer except palliation
Treatment of Chronic Lifestyle Disorders like neurodegenerative disorders is often very disappointing and limited by adverse events
It treats the Disease (symptomatic) and not the patient ‘as a whole’ (Holistic approach)
Therapeutic Objective
The ultimate goal of every physician is to “CURE” the disease.
Has Allopathy achieved this goal for all ailments? No; Except for infective pathologies, we do not achieve CURE
Most often the treatment is Symptomatic and Palliative.
Effective & Safe Medicine
Drug Discovery – problems
It is notoriously inefficient One in a hundred thousand or more compounds will
enter the market as a drug Pharma majors have NO interest in higher plants
extracts for screening for biological activity In NAPRALERT ethnomedical reports for 14,300
species (5.2% of all plant species) are there; But 58% of these species have never been examined
biologically or chemically Of these 74% are used in a manner which parallels
their ethnomedical use
Traditional medicine
Modern scienceModern medicine
Golden triangle
Thus making cheaper affordable and safe medicine
Mashelkar 2005
Compound Plant Species
Acetyl digoxin Digitalis lanata
Ajmalicine Catharanthus roseus, Rauwolfia sp.
Ajmmaline Rauvolfia serpentina
Andrographolide Andrographis paniculata
Artemissine Artemisia annua
Asiaticoside Centella asiatica
Berberine Berberis spp.
Caffeine Camellia sinensis
Caffeine Camellia sinensis
Cocaine Erythroxylum cocoa
Codeine Papaver spp.
Codiene Papaver somniferum
Colchicine Colchicum autumnale, Gloriosa superba
Curcumin Curcuma longa
Digitoxin, Digoxin, Digitoxigenin Digitalis spp.
Emetine Cephaelis ipecacuanha
Ephedrine Ephedra gerardiana
Ergometrine, Ergotamine, Ergotoxin Claviceps purpurea on Rye plants
Glycyrrhizin, Glycyrrhizinic acid Glycyrrhiza glabra
Hesperidin Citrus spp. Mentha spp.
Examples of some important plant derived drugs
Contd..
Hyoscine Duboisia spp.
Hyoscyamine Datura spp, Hyscyamus spp.
L-Dopa Mucuna pruriens
Menthol Mentha spp.
Morphine Papaver spp.
Papain Carica papaya
Podophyliotoxin Podophyllum emodi
Quinine, Quinidine Cinchona spp.
Reserpine & Deserpidine Rauvolfia serpentina,
Rutin Eucalyptus spp, Fagopyrum spp, Sophora japonica
Scopolamin Datura sp.
Sennosides A&B Cassia angustifolia, C. acutifolia
Silymarin Silybum marianum
Strychnine Strychnos nux-vomica
Taxol Taxus baccata
Thymol Thymus vulgaris
Vinblastine, Vincristine Catharanthus roseus
Xanthotoxin Ammi majus, Heracleum candicans
Chemical Intermediates
Citral Lemon grass
Diosgenin Dioscorea spp. Costus spp.
Phytosterols (Stigmasterol & Sitosterol) Soya & Calabar Beans
Solasodine Solanum
Hypercin, Hyperforin Hypericum perforatum
Examples of some important plant derived drugs (Contd..)
Traditional medicineHistorical background
Earliest recorded use of a medicinal plant has been mentioned in ‘Rigveda’
one mentioned in the modern texts is that of the herb called “Ma huang” a species of Ephedra used medicinally in China for over 5000 years
Cinchona was used by local south American tribes long before before the isolation of quinine for treating malaria
Source of aspirin (Salix officinalis) was used as pain killer for long time before being identified
Traditional medicines
Middle of 19th century, 80% of all medicines were herbal
Even today 25% of drugs are derived from plant source
Most of these drugs came from traditional lead, folk knowledge etc.
Some of these still could not substituted despite the enormous advancement in synthetic chemistry eg. Reserpine, taxol, vincristine etc.
Revival of herbal medicine
widespread belief that ‘green’ medicine is healthier than synthetic products
leading to rapid spurt of demand for health products like herbal tea, ginseng and such products of traditional medicine
So rapid – sale of herbal products are staggering 100 billion dollars a year.
After India and China, even the western world has started working on herbals
NIH has set up CAM center and working on St. John’s wort and Gingko biloba
Drug development based on traditional leadsSurvey of traditional remedies
Choice of plant
Identification,authentication
CollectionTraditional formulation
Clinicaltrial
Related species
Extraction
Biologicalscreening
Effective
1. Analytical standard
2. Safety
3. Modernise Technology
4. New Dosage Forms
Active
Bioassay Linked Fractionation
Active Compound(s) Characterisation
Pure Compound, Standardised Extracts
Clinical Trials
CommercialProduction
Marketing
1. Pharmacology2. Toxicity3. Clinical Pharmacology
Bio-availabilityRegistration
Pharmacokinetics/PharmacodynamicsPilot Plant Production
Reverse pharmacology
What is required is “Scientific evidence” Answer lies in providing scientific validation
for efficacy and safety Screening based on ethnomedical and
ethnobotanical lead as chances of hitting the target is more
System biology
The health triangle. The survival potential of all living systems, H, is expressed in the health triangle, structured with life’s common denominator: Intelligence, Energy and Organization.
Synergy
Most of the effective phytomedicine in market are as whole extracts of plants
Practitioners believe that synergistic interactions between the components of individual or mixture of herbs are a vital part of therapeutic efficacy
Mechanism of action of many phytomedicine is still unknown and there are several instance where total extract shows better activity than an equalent dose of isolated compound
chemical and pharmacological evidence to demonstrate conclusively the concept of synergism
Multi-target approach
Combinations of herbs are normal and are based on empirical observation and reasoning based on a particular patient
these herbal combinations may not be targeted to a particular organ (multi-targeted), cell, tissue or any biochemical system, making this synergy even more difficult to identify
possibility of drug interactions and the adverse reactions arising out of these have to be checked before coming out with the drug
Plant A
Plant B
Plant C
Plant D
Plant E
Plant F
Plant G
Plant H
Pain, CartilageInflammation Oxidative stress Osteoporosis Anabolic CNS ImmunomodulatorAntistressBioavailabilityLubricant
Multiple Targets Need A Combo
Activity Matrix: Systems-Biology Approach
Pharmacovigilance
Any thing herbal is safe!!????? Adverse drug reactions (ADR) Drug-drug interactions Herb-Drug interactions Toxicity of the isolated ingredients Traditional process (Shodhana)
Traditional Medicine: Threats
Poor positioning on a global level Ignored by the global scientific community Very little scientific research validations Very little publications in peer-reviewed
science Journals Deliberate negative propagandas
Traditional medicine: Future
Innovative, Effective and Aggressive use of Emerging Technologies without Compromising the Basic Principles will be the main key towards the bright future
Pharmacological studies
Extraction and fractionation
Activity guided isolation of active copounds
Traditional Approach
Selection of potential plants
Formulation and Doasge studies
Toxicity stuides Standardization of the formulation(s)
Clinical studies
IPR
Final Product
Global Market
Drug Discovery